Cinnamon: A systematic review of adverse events - PubMed (original) (raw)
. 2019 Apr;38(2):594-602.
doi: 10.1016/j.clnu.2018.03.013. Epub 2018 Apr 5.
Affiliations
- PMID: 29661513
- DOI: 10.1016/j.clnu.2018.03.013
Cinnamon: A systematic review of adverse events
Mahdie Hajimonfarednejad et al. Clin Nutr. 2019 Apr.
Abstract
Cinnamon, from the genus Cinnamomum and Lauraceae family, has been used as a popular spice for thousands of years around the world. Many studies have shown therapeutic effects of cinnamon including its antimicrobial, antiviral, antifungal, antioxidant, antitumor, antihypertensive, antilipemic, antidiabetic, gastroprotective, and immunomodulatory effects. Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon, we aimed to systematically review its human reports of adverse event. Databases including Medline, Scopus, Science Direct, Embase, PubMed Central and Google scholar were searched using the key words "cinnamon" or "cinnamomum" for clinical trials, case reports and case series. Also spontaneous reports about adverse effects of cinnamon were collected from five national and international spontaneous reporting schemes. Thirty eight clinical trials were found, five of them reported adverse events. Twenty case reports and seven case series, as well as, spontaneous reports including 160 adverse events were also included. The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self-limiting in the majority of cases. The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent, its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored.
Keywords: Adverse effect; Adverse event; Cinnamon; Safety; Systematic review.
Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Similar articles
- [Eating cinnamon in cinnamaldehyde allergy].
Hürlimann AF, Wüthrich B. Hürlimann AF, et al. Hautarzt. 1995 Sep;46(9):660-1. doi: 10.1007/s001050050316. Hautarzt. 1995. PMID: 7591774 German. No abstract available. - Oral adverse reactions due to cinnamon-flavoured chewing gums consumption.
Calapai G, Miroddi M, Mannucci C, Minciullo P, Gangemi S. Calapai G, et al. Oral Dis. 2014 Oct;20(7):637-43. doi: 10.1111/odi.12170. Epub 2013 Sep 4. Oral Dis. 2014. PMID: 24004186 Review. - Oral leukoplakia caused by cinnamon food allergy.
Mihail RC. Mihail RC. J Otolaryngol. 1992 Oct;21(5):366-7. J Otolaryngol. 1992. PMID: 1469757 - Pharmacological properties and their medicinal uses of Cinnamomum: a review.
Kumar S, Kumari R, Mishra S. Kumar S, et al. J Pharm Pharmacol. 2019 Dec;71(12):1735-1761. doi: 10.1111/jphp.13173. Epub 2019 Oct 23. J Pharm Pharmacol. 2019. PMID: 31646653 Review. - Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review.
Ranasinghe P, Pigera S, Premakumara GA, Galappaththy P, Constantine GR, Katulanda P. Ranasinghe P, et al. BMC Complement Altern Med. 2013 Oct 22;13:275. doi: 10.1186/1472-6882-13-275. BMC Complement Altern Med. 2013. PMID: 24148965 Free PMC article. Review.
Cited by
- Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial.
Moreira FD, Reis CEG, Gallassi AD, Moreira DC, Welker AF. Moreira FD, et al. PLoS One. 2024 Oct 9;19(10):e0311501. doi: 10.1371/journal.pone.0311501. eCollection 2024. PLoS One. 2024. PMID: 39383145 Free PMC article. Clinical Trial. - Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.
Abankwah JK, Wang Y, Wang J, Ogbe SE, Pozzo LD, Chu X, Bian Y. Abankwah JK, et al. Heliyon. 2024 Sep 12;10(19):e37883. doi: 10.1016/j.heliyon.2024.e37883. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39381110 Free PMC article. Review. - Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies.
Farhadnejad H, Saber N, Neshatbini Tehrani A, Kazemi Jahromi M, Mokhtari E, Norouzzadeh M, Teymoori F, Asghari G, Mirmiran P, Azizi F. Farhadnejad H, et al. J Nutr Metab. 2024 Jul 10;2024:8300428. doi: 10.1155/2024/8300428. eCollection 2024. J Nutr Metab. 2024. PMID: 39021815 Free PMC article. Review. - Cardiovascular Effects of Herbal Products and Their Interaction with Antihypertensive Drugs-Comprehensive Review.
Nyulas KI, Simon-Szabó Z, Pál S, Fodor MA, Dénes L, Cseh MJ, Barabás-Hajdu E, Csipor B, Szakács J, Preg Z, Germán-Salló M, Nemes-Nagy E. Nyulas KI, et al. Int J Mol Sci. 2024 Jun 9;25(12):6388. doi: 10.3390/ijms25126388. Int J Mol Sci. 2024. PMID: 38928095 Free PMC article. Review. - Development of a Functional Acceptable Diabetic and Plant-Based Snack Bar Using Mushroom (Coprinus comatus) Powder.
Dimopoulou M, Vareltzis P, Floros S, Androutsos O, Bargiota A, Gortzi O. Dimopoulou M, et al. Foods. 2023 Jul 14;12(14):2702. doi: 10.3390/foods12142702. Foods. 2023. PMID: 37509794 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical